Yahoo Web Search

  1. Easily search historical records in our extensive collections. Start your free trial now! Online obituary search engine that contains billions of records.

Search results

  1. H. Michael Shepard (born 1949) is an American cancer researcher who was awarded the 2007 Harvard Medical School Warren Alpert Foundation Prize and the 2019 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin [1]

  2. funeral-notices.co.uk › national › death-noticesFuneral Notices

    Find local and national death notices, funeral notices, obituaries, in memoriams, acknowledgements and family announcements including birthdays, births, anniversaries and marriages at funeral-notices.co.uk.

  3. Mar 15, 2024 · In this World View, H. Michael Shepard describes his personal story behind the discovery of trastuzumab, 25 years since its FDA approval for HER2-overexpressing breast cancers.

  4. Sep 10, 2019 · The 2019 Lasker~DeBakey Clinical Medical Research Award recognizes H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich (Figure 1) for their contributions to the development of the HER2-targeting monoclonal antibody (mAb), Herceptin (also known as trastuzumab), the first of its kind to effectively target a cancer-associated protein and ...

    • Corinne L. Williams
    • 10.1172/JCI132533
    • 2019
    • 2019/09/09
  5. Dr H. Michael Shepard, PhD. SCIENTIFIC ADVISOR. Biography. After completing a PhD in Cellular, Molecular and Developmental Biology at Indiana University (IU), Bloomington, and then a successful Walter Winchell-Damon Runyon postdoctoral fellowship, also in the Biology Department at IU, Shepard joined Genentech in 1980.

  6. Sep 24, 2019 · Dr. H. Michael Shepard and his team have identified a critical breast cancer biomarker and developed the drug Herceptin, which can treat more than just breast cancer. They recently won the...

  7. People also ask

  8. Dr. H. Michael Shepard is a global, leading authority on cancer research and therapeutics. Best known for his invention of “Herceptin”/Trastuzumab, which has remained one of the most profitable platforms for Roche (>$7B USD).

  1. People also search for